Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
Abstract Background Currently, serum PSA is the most commonly used screening tool in clinical practice. However, PSA levels in the range of 4–10 ng/ml are considered the ‘grey zone’ of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-01-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-01760-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861819126579200 |
|---|---|
| author | Yuxuan Chen Haisheng Yan Yaoqin Xu Kexin Chen Runqin Yang Jiali Yang Ruian Zhu Rui Lin Jiang Wang Jie Liu Pingsheng Gao Lei Pang Lexin Wang |
| author_facet | Yuxuan Chen Haisheng Yan Yaoqin Xu Kexin Chen Runqin Yang Jiali Yang Ruian Zhu Rui Lin Jiang Wang Jie Liu Pingsheng Gao Lei Pang Lexin Wang |
| author_sort | Yuxuan Chen |
| collection | DOAJ |
| description | Abstract Background Currently, serum PSA is the most commonly used screening tool in clinical practice. However, PSA levels in the range of 4–10 ng/ml are considered the ‘grey zone’ of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such as PSA ratio, PSA density, and other indices to determine the necessity of prostate biopsy (PBx). Despite this, patients in the ‘grey zone’ still have a low rate of positive biopsy results. Neutrophils have been found to be associated with tumor development and inflammation. Based on this, we combined PSA and absolute neutrophil counts to calculate the total PSA to absolute neutrophil ratio (PNR), which is higher in patients with prostate cancer and lower in those with benign conditions. PNR is elevated in prostate cancer patients compared to those with prostate enlargement. Therefore, the aim of this study is to explore the diagnostic efficacy of PNR for prostate cancer across different PSA intervals and to provide new insights into the diagnosis, treatment, and screening strategies for prostate cancer. Objective In this study, we explored the predictive value of prostate-specific antigen-to-neutrophil ratio (PNR) for the diagnosis of prostate cancer, with a view to further improving the diagnostic accuracy of prostate cancer. Methods Patients were grouped in three different divisions of PSA 4–10 ng/ml, 10–20 ng/ml, > 20 ng/ml, We grouped the patients and compared the test data such as age, PSA, PSA-density (PSAD), and prostate-specific antigen-to-neutrophil ratio (PNR) between the two groups of patients who had puncture results of prostate cancer and non-prostate cancer at the same time using Log regression test to verify the diagnostic value of PNR. Results When PSA levels are in the range of 4–10 ng/ml, an elevated PNR is an independent risk factor for prostate cancer. In this range, the diagnostic value of f/t PSA and PSAD for prostate cancer is limited. However, the use of PNR can significantly enhance the diagnostic efficacy for prostate cancer and thereby effectively reduce the incidence of unnecessary prostate biopsies. |
| format | Article |
| id | doaj-art-8a78b3a7fb4c464db87b70f87f1a82ef |
| institution | Kabale University |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-8a78b3a7fb4c464db87b70f87f1a82ef2025-02-09T12:43:33ZengSpringerDiscover Oncology2730-60112025-01-0116111110.1007/s12672-025-01760-8Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancerYuxuan Chen0Haisheng Yan1Yaoqin Xu2Kexin Chen3Runqin Yang4Jiali Yang5Ruian Zhu6Rui Lin7Jiang Wang8Jie Liu9Pingsheng Gao10Lei Pang11Lexin Wang12Department of Urology, People’s Hospital of Ningxia Hui Autonomous RegionNingxia Medical UniversityNingxia Medical UniversityNingxia Medical UniversityNingxia Medical UniversityDepartment of Urology, People’s Hospital of Ningxia Hui Autonomous RegionWestern Institute of Digital-Intelligent MedicineSchool of Clinical Medicine, The Affiliated Hospital, Southwest Medical UniversitySchool of Clinical Medicine, The Affiliated Hospital, Southwest Medical UniversityDepartment of General Surgery, Dazhou Central HospitalDepartment of Urology, People’s Hospital of Ningxia Hui Autonomous RegionDepartment of Clinical Research Center, Dazhou Central HospitalDepartment of Urology, People’s Hospital of Ningxia Hui Autonomous RegionAbstract Background Currently, serum PSA is the most commonly used screening tool in clinical practice. However, PSA levels in the range of 4–10 ng/ml are considered the ‘grey zone’ of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such as PSA ratio, PSA density, and other indices to determine the necessity of prostate biopsy (PBx). Despite this, patients in the ‘grey zone’ still have a low rate of positive biopsy results. Neutrophils have been found to be associated with tumor development and inflammation. Based on this, we combined PSA and absolute neutrophil counts to calculate the total PSA to absolute neutrophil ratio (PNR), which is higher in patients with prostate cancer and lower in those with benign conditions. PNR is elevated in prostate cancer patients compared to those with prostate enlargement. Therefore, the aim of this study is to explore the diagnostic efficacy of PNR for prostate cancer across different PSA intervals and to provide new insights into the diagnosis, treatment, and screening strategies for prostate cancer. Objective In this study, we explored the predictive value of prostate-specific antigen-to-neutrophil ratio (PNR) for the diagnosis of prostate cancer, with a view to further improving the diagnostic accuracy of prostate cancer. Methods Patients were grouped in three different divisions of PSA 4–10 ng/ml, 10–20 ng/ml, > 20 ng/ml, We grouped the patients and compared the test data such as age, PSA, PSA-density (PSAD), and prostate-specific antigen-to-neutrophil ratio (PNR) between the two groups of patients who had puncture results of prostate cancer and non-prostate cancer at the same time using Log regression test to verify the diagnostic value of PNR. Results When PSA levels are in the range of 4–10 ng/ml, an elevated PNR is an independent risk factor for prostate cancer. In this range, the diagnostic value of f/t PSA and PSAD for prostate cancer is limited. However, the use of PNR can significantly enhance the diagnostic efficacy for prostate cancer and thereby effectively reduce the incidence of unnecessary prostate biopsies.https://doi.org/10.1007/s12672-025-01760-8Prostate cancerNeutPSAPNRProstate puncture biopsy |
| spellingShingle | Yuxuan Chen Haisheng Yan Yaoqin Xu Kexin Chen Runqin Yang Jiali Yang Ruian Zhu Rui Lin Jiang Wang Jie Liu Pingsheng Gao Lei Pang Lexin Wang Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer Discover Oncology Prostate cancer Neut PSA PNR Prostate puncture biopsy |
| title | Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer |
| title_full | Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer |
| title_fullStr | Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer |
| title_full_unstemmed | Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer |
| title_short | Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer |
| title_sort | analysis of the predictive value of the prostate specific antigen to neutrophil ratio for the diagnosis of prostate cancer |
| topic | Prostate cancer Neut PSA PNR Prostate puncture biopsy |
| url | https://doi.org/10.1007/s12672-025-01760-8 |
| work_keys_str_mv | AT yuxuanchen analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT haishengyan analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT yaoqinxu analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT kexinchen analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT runqinyang analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT jialiyang analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT ruianzhu analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT ruilin analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT jiangwang analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT jieliu analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT pingshenggao analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT leipang analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer AT lexinwang analysisofthepredictivevalueoftheprostatespecificantigentoneutrophilratioforthediagnosisofprostatecancer |